The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients ...
The author writes "In the realm of insurance coverage litigation, whether two or more claims filed in different time periods ...
Highlights The Delaware Supreme Court took a broad view of relatedness, holding that an SEC investigation and later class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback